Oramed Pharmaceuticals Inc. financial data

Symbol
ORMP on Nasdaq
Industry
Pharmaceutical Preparations
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Integrated Security Technologies, Inc. (to 4/10/2006), IGUANA VENTURES LTD (to 6/10/2004)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 664 % -6.55%
Return On Equity 2.7 %
Return On Assets 2.31 %
Operating Margin -1.01K % +30.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40.3M shares -0.07%
Common Stock, Shares, Outstanding 40.2M shares -0.18%
Entity Public Float 131M USD -23%
Common Stock, Value, Issued 484K USD 0%
Weighted Average Number of Shares Outstanding, Basic 40.9M shares +1.12%
Weighted Average Number of Shares Outstanding, Diluted 40.9M shares +1.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.93M USD 0%
Research and Development Expense 6.63M USD -59.2%
Selling and Marketing Expense -663K USD -243%
General and Administrative Expense 6.43M USD -28.8%
Operating Income (Loss) -13.1M USD +46.1%
Nonoperating Income (Expense) 22.3M USD -3645%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -18.5M USD -464%
Income Tax Expense (Benefit) 1.13M USD
Net Income (Loss) Attributable to Parent 4.47M USD -509%
Earnings Per Share, Basic 0.11 USD/shares -8.33%
Earnings Per Share, Diluted 0.11 USD/shares -8.33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.6M USD
Marketable Securities, Current 646K USD
Assets, Current 143M USD -18.7%
Other Long-term Investments 7.16M USD
Property, Plant and Equipment, Net 718K USD -22.2%
Operating Lease, Right-of-Use Asset 486K USD -36.7%
Assets 165M USD -28.5%
Employee-related Liabilities, Current 453K USD -14.4%
Liabilities, Current 5.27M USD -93.3%
Contract with Customer, Liability, Noncurrent 4M USD
Operating Lease, Liability, Noncurrent 186K USD -52.2%
Other Liabilities, Noncurrent 60K USD
Retained Earnings (Accumulated Deficit) -166M USD +2.61%
Stockholders' Equity Attributable to Parent 156M USD +4.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 156M USD +4.92%
Liabilities and Equity 165M USD -28.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.48M USD +73.4%
Net Cash Provided by (Used in) Financing Activities -19M USD -882%
Net Cash Provided by (Used in) Investing Activities 30M USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 40.2M shares -0.18%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9.52M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.1M USD +670%
Interest Paid, Excluding Capitalized Interest, Operating Activities 571K USD
Deferred Tax Assets, Valuation Allowance 28.5M USD -13.2%
Operating Lease, Liability 429K USD -33%
Depreciation 56K USD +51.4%
Payments to Acquire Property, Plant, and Equipment 2K USD -99%
Lessee, Operating Lease, Liability, to be Paid 445K USD -33.3%
Operating Lease, Liability, Current 243K USD -3.19%
Lessee, Operating Lease, Liability, to be Paid, Year Two 139K USD -33.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 221K USD -17.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16K USD -40.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD -84.2%
Deferred Tax Assets, Operating Loss Carryforwards 27.8M USD +0.53%
Unrecognized Tax Benefits 11K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10K USD 0%
Additional Paid in Capital 319M USD +5.99%
Interest Expense 592K USD